Neurolite
Generic name: bicisate dihydrochloride
Dosage form: injection
Drug class:Radiologic conjugating agents
Medically reviewed by Drugs.com. Last updated on Jan 24, 2022.
On This Page
Neurolite Description
This kit formulation consists of two nonradioactive vials: Vial A contains bicisate dihydrochloride (N, N'-1,2-ethylenediylbis-L-cysteine diethyl ester dihydrochloride) and a reducing agent as a lyophilized solid and vial B contains a buffer solution. Both vials are sterile and non-pyrogenic.
| Vial A – | |
|---|---|
| Bicisate dihydrochloride (ECD•2HCl) | 0.9 mg |
| Edetate disodium, dihydrate | 0.36 mg |
| Mannitol | 24 mg |
| Stannous chloride, dihydrate, theoretical | |
| (SnCl2•2H2O) | 72 µg |
| Stannous chloride, dihydrate, | |
| minimum (SnCl2•2H2O) | 12 µg |
| Total Tin, (stannous and stannic), dihydrate | |
| (as SnCl2•2H2O) | 83 µg |
The contents of vial A are lyophilized and stored under nitrogen. The pH of the solution before lyophilization is 2.7 ± 0.25. This vial is stored at 15-25°C. Protect from light.
